Introduced
by
To establish that certain customer discounts and rebates on prescription drugs are not a violation of a “false claims act” that bans kickbacks and bribes.
Referred to the Committee on Health Policy
Reported without amendment
Refer to the Committee on Ways and Means.
Referred to the Committee on Ways and Means